Carlos Iribarren to Product Surveillance, Postmarketing
This is a "connection" page, showing publications Carlos Iribarren has written about Product Surveillance, Postmarketing.
Connection Strength
0.131
-
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma. J Allergy Clin Immunol. 2017 May; 139(5):1489-1495.e5.
Score: 0.131